Genevieve Hery
banner
hery-arnaud.bsky.social
Genevieve Hery
@hery-arnaud.bsky.social
Microbes-lover & Bridges-lover
🧫 #BacterioMed Staphylococcus aureus in all its forms.
The most observant 👀 will spot 3 distinct morphotypes, including a small-colony variant.
Sputum from a #cysticfibrosis patient still requiring antibiotics despite triple therapy. A reminder that the infectious challenge remains very real in CF.
November 11, 2025 at 7:06 AM
“Your #microbiome test says you’re in dysbiosis”? → Probably bullshit 💩.
Our paper shows how unregulated these analyses are. Time for validated, patient-safe diagnostics.
Science ≠ marketing.
@sfmicrobiologie.bsky.social @jm-sfm.bsky.social @rejif-spilf.bsky.social
👉 doi.org/10.1136/gutj...
Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories
We read with interest the review by de Vos et al .1 The human gut microbiome plays a pivotal role in the maintenance of health and the development of disease.2 3 With the growing availability of micro...
doi.org
October 28, 2025 at 8:01 AM
#BacterioMed Recurrent Clostridioides difficile infections
affect 14%-16% of patients with CDI. Up to 50% of rCDI is caused by ingestion of spores from a new toxin-producing strain. FMT: after 2 or more CDI recurrences and first-line antibiotic treatment.
jamanetwork.com/journals/jam...
Recurrent Clostridioides difficile Infections
This JAMA Insights discusses the epidemiology, diagnosis, and treatment of recurrent Clostridioides difficile infections.
jamanetwork.com
October 21, 2025 at 9:32 AM
🧬 Nasal bacterial communities co-develop with respiratory immunity early in life, linking dysbiosis to systemic monocyte signature and wheezing by @benjmarsland.bsky.social
#Microbiome #Immunity #EarlyLife #RespiratoryHealth
www.science.org/doi/10.1126/...
Bacterial communities co-develop with respiratory immunity early in life, linking dysbiosis to systemic monocyte signature and wheezing
Bacteria-only airway microbiota comatures with newborn’s immunity, linking systemic monocyte signature with previous wheeze.
www.science.org
October 18, 2025 at 8:14 PM
🎉 New paper out in @cellpress.bsky.social @isciences.bsky.social! @insermgrandouest.bsky.social
💡Integrating #microbiome data into clinical research → Sharper insights, better innovative therapies. #PrecisionMedicine #RCT
👉https://www.sciencedirect.com/science/article/pii/S2589004225020152
October 15, 2025 at 12:14 PM
#BacterioMed This new WHO report presents a global analysis of antibiotic resistance prevalence/trends, drawing on ~23 million bacteriologically confirmed cases of bloodstream infections, urinary tract infections, gastrointestinal infections, and urogenital gonorrhoea. www.who.int/publications...
Global antibiotic resistance surveillance report 2025
This new WHO report presents a global analysis of antibiotic resistance prevalence and trends, drawing on more than 23 million bacteriologically confirmed cases of bloodstream infections, urinary trac...
www.who.int
October 14, 2025 at 5:24 AM
🧫 The scars of war also appear in the antibiogram. #BacterioMed
A Ukrainian war-injured patient, with a Citrobacter freundii osteitis producing a carbapenemase. The first-line antibiogram offered almost no therapeutic options.
#AntimicrobialResistance #WarAndHealth #GlobalHealth
October 8, 2025 at 5:27 PM
Reposted by Genevieve Hery
#NobelPrize : Marie Brunkow, Fred Ramsdell et Shimon Sakaguchi reçoivent à l'instant le #Nobel de Médecine et Physiologie pour leurs travaux sur la tolérance immunitaire 🧫
October 6, 2025 at 9:41 AM
As the years go by, I realize how deeply fortunate I was to grow up surrounded by such a landscape. It quietly sculpts a backbone that lasts a lifetime. #Brittany
October 5, 2025 at 4:38 PM
Retour sur la #JILB 2025, magnifique édition !
👏🏼🙏🏻 aux intervenants, notamment Manuel Etienne @churouen.bsky.social, Béatrice Grasland @anses-fr.bsky.social. Heureuse de cette belle dynamique du réseau d’ #infectiologie #microbiologie du littoral breton 🌊! @rejif-spilf.bsky.social @jm-sfm.bsky.social
October 4, 2025 at 1:51 PM
✨ Just for the sheer beauty of bacteria: the metallic, iridescent sheen of #Pseudomonas aeruginosa.
🧫 A pathogen… but also an artist of light and color when grown in culture. #BacterioMed #ScienceArt @sfmicrobiologie.bsky.social @jm-sfm.bsky.social @ricaifrance.bsky.social
October 1, 2025 at 4:38 AM
🫁 Our latest paper: Sputum sampling is a reliable alternative to nasopharyngeal swabs for virological diagnosis of respiratory infections in #cysticfibrosis.
A 3y, 11-center study supported by #VaincrelaMucoviscidose
#LungInfections @sfmicrobiologie.bsky.social www.resmedjournal.com/article/S095...
MOLECULAR DIAGNOSIS OF RESPIRATORY VIRAL INFECTIONS IN CYSTIC FIBROSIS, SPUTUM VERSUS NASOPHARYNGEAL SAMPLES
Respiratory viral infections in people with Cystic Fibrosis (pwCF) significantly impact disease progression, and their molecular diagnosis should be part of the recommendations. Sputum, the routinely ...
www.resmedjournal.com
September 28, 2025 at 9:37 AM
🫁🦠 GREPI 2025 : le RDV incontournable sur l’infection pulmonaire !
Pneumologues, infectiologues, microbiologistes, infirmières, kinésithérapeutes, venez nombreux !
📅 13-14 novembre 2025
📍 Chantilly 🏰
✨ Prix GREPI Junior : appel à résumés en cours
👉 www.journeesgrepi
September 27, 2025 at 8:16 AM
🗻Mount Fuji? No, Nocardia! 🧫
🫁 Pulmonary infection in an immunocompromised patient. #BacterioMed
September 26, 2025 at 6:56 PM
A #MustRead 🫁🛡️🦠
Innate immunity of the lungs in homeostasis and disease www.mucosalimmunology.org/article/S193...
September 26, 2025 at 1:08 PM
🫁 Pulmonary #microbiota matters!
New article coordinated by Guillard CHU Reims. Stable #COPD Extended culture + 16S NGS
🧬 With Center for Biome Analysis and Microbiota (CBAM) CHU Brest, as partner for #microbiome analysis. Strong recognition of its expertise!
🔗 www.nature.com/articles/s41...
Association between exacerbation history and airway bacterial community assessed by extended bacterial culture and sequencing approaches in stable COPD - Scientific Reports
Scientific Reports - Association between exacerbation history and airway bacterial community assessed by extended bacterial culture and sequencing approaches in stable COPD
www.nature.com
September 26, 2025 at 7:24 AM
#BacterioMed Uncommon antibiotype for Citrobacter farmeri, showing a hyper OXY-like profile.
C. farmeri belongs to the Citrobacter amalonaticus group.
⚠️ Beware: immunochromatographic tests may misidentify it as CTX-M. This resistance in C. farmeri is chromosomally encoded.
doi.org/10.1016/j.di...
September 21, 2025 at 12:25 PM
#GramArt Nothing bacterial here. Just the quiet beauty of a blood smear, where staining artifacts sketch out something close to art. #BacterioMed
September 20, 2025 at 1:42 PM
#BacterioMed Bacteremia caused by Lactobacillus plantarum (Lactiplantibacillus plantarum) in a patient who underwent digestive surgery.
So glad to have had early identification right from the Gram stain: crucial for guiding probabilistic antibiotic therapy, given this species’ resistance profile.
September 20, 2025 at 1:30 PM
Reposted by Genevieve Hery
Researchers identify bacteria in the maternal gut microbiome linked to a higher risk of preterm birth. www.cell.com/cell-host-mi...

@cp-cellhostmicrobe.bsky.social
#WestLakeUniversity Ju-Sheng Zheng & colleagues
September 10, 2025 at 3:00 PM
#BacterioMed The mucoidy of P. aeruginosa can be seen right from the Gram for expert eyes. Note the thick gangue surrounding Gram-negative bacilli: it corresponds to the exopolysaccharides produced by the bacteria. It's easy to see why antibiotics are not very effective at this stage of 🫁infection.
July 31, 2025 at 4:37 PM
The call of the ocean.
July 8, 2025 at 1:40 PM
🫁🦠 [Article] Preuve de concept pour une phagothérapie inhalée ciblant l'infection chronique à P. aeruginosa chez 9 patients atteints de mucoviscidose.
Bonne tolérance, effet antibactérien, délivrance efficace via nébulisation, analyse du #microbiote pulmonaire en sus 👏
www.nature.com/articles/s41...
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial - Nature Communications
In a randomized, placebo-controlled trial, an inhaled phage cocktail was well tolerated in adults with cystic fibrosis and chronic Pseudomonas aeruginosa infection, with evidence of lung delivery and ...
www.nature.com
July 6, 2025 at 7:09 AM